Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
30 participants
INTERVENTIONAL
2007-07-31
2007-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
low level laser instrument (Painless Light PL-830, Advanced Chips \& Products Crop., USA)
diode laser
wavelength at 830nm, 9.7J/cm2 for 10 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diode laser
wavelength at 830nm, 9.7J/cm2 for 10 min
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first onset of CTS more than 1 year ago with repeated episodes
* never having laser treatment before.
Exclusion Criteria
* history of metabolic disease or paralyzed limbs caused by stroke
* taking any anti-inflammatory drug
* with other treatments, such as acupuncture, physical therapy and wearing orthosis
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University
OTHER
Chung Shan Medical University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chin-Ping Han, MD/PhD
Role: STUDY_DIRECTOR
Chung Shan Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chung Shan Medical University Hospital
Chinese Taipei, Taiwan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS07040
Identifier Type: -
Identifier Source: org_study_id